Cancer-associated bone disease (Q61217357)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

title

Cancer-associated bone disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

Jorge B Cannata-andía

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

Abdellah El Maghraoui

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

Nicola Napoli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

author name string

R Rizzoli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

J-J Body

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

M-L Brandi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

D Chappard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

C C Glüer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

D Kendler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

A Papaioannou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

D D Pierroz

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

M Rahme

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

C H Van Poznak

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

T J de Villiers

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

G El Hajj Fuleihan

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

22 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

Osteoporosis International

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

2929-2953

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

Skeletal sequelae of cancer and cancer treatment

28 February 2020

cites work

1 reference

12 December 2020

The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel

1 reference

12 December 2020

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

1 reference

12 December 2020

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

12 December 2020

Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study

1 reference

12 December 2020

1 reference

12 December 2020

Osteoporosis from androgen deprivation therapy in prostate cancer treatment.

1 reference

12 December 2020

Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial

1 reference

12 December 2020

Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis

1 reference

12 December 2020

Pathological fracture prediction in patients with metastatic lesions can be improved with quantitative computed tomography based computer models.

1 reference

12 December 2020

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

1 reference

12 December 2020

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis

1 reference

12 December 2020

Bone metastasis: pathogenesis and therapeutic implications

1 reference

12 December 2020

A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world

1 reference

12 December 2020

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis

1 reference

12 December 2020

Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER breast cancer

1 reference

12 December 2020

Patterns of relapse and modalities of treatment of breast cancer: the 'IRIS' Project, a multicenter observational study

1 reference

12 December 2020

RETRACTED: Amelioration of Osteoporosis and Hypovitaminosis D by Sunlight Exposure in Hospitalized, Elderly Women With Alzheimer's Disease: A Randomized Controlled Trial

1 reference

12 December 2020

Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.

1 reference

12 December 2020

Predicting the strength of femoral shafts with and without metastatic lesions

1 reference

12 December 2020

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

1 reference

12 December 2020

Breast-cancer adjuvant therapy with zoledronic acid

1 reference

12 December 2020

Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer

1 reference

12 December 2020

Bone mineral density and prevalent osteoarthritis of the hip in older men for the Osteoporotic Fractures in Men (MrOS) Study Group

1 reference

12 December 2020

Assessment of individual fracture risk: FRAX and beyond.

1 reference

12 December 2020

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

1 reference

12 December 2020

Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy.

1 reference

12 December 2020

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

1 reference

12 December 2020

Prevention of falls in the elderly--a review.

1 reference

12 December 2020

Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivo

1 reference

12 December 2020

A family history of fracture and fracture risk: a meta-analysis.

1 reference

12 December 2020

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

1 reference

12 December 2020

Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy

1 reference

12 December 2020

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

1 reference

12 December 2020

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer

1 reference

12 December 2020

High prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer

1 reference

12 December 2020

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

12 December 2020

Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial

1 reference

12 December 2020

Osteoporosis and fractures after androgen deprivation initiation for prostate cancer.

1 reference

12 December 2020

Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer

1 reference

12 December 2020

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

1 reference

12 December 2020

American society of clinical oncology clinical practice guideline update: recommendations on the role of bone-modifying agents in metastatic breast cancer

1 reference

12 December 2020

Bisphosphonates for post-menopausal osteoporosis: are they all the same?

1 reference

12 December 2020

American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma

1 reference

12 December 2020

Mechanisms of bone metastasis

1 reference

12 December 2020

Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.

1 reference

12 December 2020

Biomarkers of clinical trials using molecular inhibitors and radiotherapy: state-of-the-art. Preface

1 reference

12 December 2020

Osteoporosis after orchiectomy for prostate cancer

1 reference

12 December 2020

Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.

1 reference

12 December 2020

Regulation of cancer cell migration and bone metastasis by RANKL.

1 reference

12 December 2020

American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

1 reference

12 December 2020

Aging and osteoporosis in breast and prostate cancer

1 reference

12 December 2020

Osteoporosis Canada 2010 guidelines for the assessment of fracture risk

1 reference

12 December 2020

Effects of third-generation aromatase inhibitors on bone

1 reference

12 December 2020

Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study

1 reference

12 December 2020

Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices

1 reference

12 December 2020

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

1 reference

12 December 2020

Practical guidance for the management of aromatase inhibitor-associated bone loss

1 reference

12 December 2020

The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate

1 reference

12 December 2020

Male gonadal toxicity

1 reference

12 December 2020

Corticosteroid induced osteoporosis. Guidelines for treatment

1 reference

12 December 2020

Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer

1 reference

12 December 2020

Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)

1 reference

12 December 2020

Cancer treatment-induced bone loss in breast and prostate cancer

1 reference

12 December 2020

Histologic evidence of an abnormal bone remodeling in B-cell malignancies other than multiple myeloma

1 reference

12 December 2020

Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.

1 reference

12 December 2020

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

1 reference

12 December 2020

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

1 reference

12 December 2020

Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study

1 reference

12 December 2020

Vertebral fracture assessment (VFA) with a densitometer predicts future fractures in elderly women unselected for osteoporosis.

1 reference

12 December 2020

[Corticosteroid-induced osteoporosis]

1 reference

12 December 2020

The Fracture Risk Assessment Tool (FRAX®): Applications in Clinical Practice

1 reference

12 December 2020

Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial

1 reference

12 December 2020

Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

Development and use of FRAX in osteoporosis

1 reference

12 December 2020

Risks of osteoporosis associated with breast cancer treatment: the need to access to preventive treatment

1 reference

12 December 2020

The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae

1 reference

12 December 2020

A high incidence of vertebral fracture in women with breast cancer

1 reference

12 December 2020

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809

1 reference

12 December 2020

Insufficiency fractures after pelvic radiotherapy in patients with prostate cancer

1 reference

12 December 2020

Osteoporosis and prostate cancer

1 reference

12 December 2020

Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment

1 reference

12 December 2020

Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy

1 reference

12 December 2020

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

1 reference

12 December 2020

Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer

1 reference

12 December 2020

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma

1 reference

12 December 2020

Peripheral or axial bone density measurements to identify osteoporosis in prostate cancer patients undergoing androgen deprivation therapy?

1 reference

12 December 2020

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

12 December 2020

Mechanisms of osteoporosis after hematopoietic cell transplantation

1 reference

12 December 2020

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

1 reference

12 December 2020

Update on identifying and managing osteoporosis in women with breast cancer

1 reference

12 December 2020

Interpretation and use of FRAX in clinical practice

1 reference

12 December 2020

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

1 reference

12 December 2020

Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition

1 reference

12 December 2020

The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network

1 reference

12 December 2020

Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years

1 reference

12 December 2020

Molecular mechanisms of osteolytic bone metastases

1 reference

12 December 2020

Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis

1 reference

12 December 2020

Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer

1 reference

12 December 2020

Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

1 reference

12 December 2020

Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors

1 reference

12 December 2020

Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study

1 reference

12 December 2020

Calcium supplements and cardiovascular risk in the Women's Health Initiative.

1 reference

12 December 2020

Evaluation of long-term toxicity after chemotherapy for testicular cancer

1 reference

12 December 2020

Consensus on the utility of bone markers in the malignant bone disease setting

1 reference

12 December 2020

Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer

1 reference

12 December 2020

Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients

1 reference

12 December 2020

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

1 reference

12 December 2020

The clinical course of bone metastases from breast cancer

1 reference

12 December 2020

Clinical features of metastatic bone disease and risk of skeletal morbidity

1 reference

12 December 2020

Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer.

1 reference

12 December 2020

International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease

1 reference

12 December 2020

Management of osteoporosis in men on androgen deprivation therapy

1 reference

12 December 2020

Serum estradiol level and risk of breast cancer during treatment with raloxifene

1 reference

12 December 2020

Bone loss in patients with breast or prostate cancer

1 reference

12 December 2020

Denosumab in men receiving androgen-deprivation therapy for prostate cancer

1 reference

12 December 2020

Bone health in adult cancer survivorship

1 reference

12 December 2020

Pathogenesis of myeloma bone disease

1 reference

12 December 2020

Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer

1 reference

12 December 2020

Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club

1 reference

12 December 2020

Quantification of dendritic cells and osteoclasts in the bone marrow of patients with monoclonal gammopathy

1 reference

12 December 2020

Prostate cancer, osteoporosis and fracture risk

1 reference

12 December 2020

Aromatase inhibitors and bone

1 reference

12 December 2020

1 reference

12 December 2020

Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment

1 reference

12 December 2020

Effects of third generation aromatase inhibitors on bone health and other safety parameters: results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women.

1 reference

12 December 2020

Serum interleukin 6 as a prognostic factor in patients with prostate cancer

1 reference

12 December 2020

Computed microtomography of bone specimens for rapid analysis of bone changes associated with malignancy.

1 reference

12 December 2020

Preanalytical variability of biochemical markers of bone turnover.

1 reference

12 December 2020

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

1 reference

12 December 2020

Abiraterone in metastatic prostate cancer.

1 reference

12 December 2020

Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens

1 reference

12 December 2020

International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients.

1 reference

12 December 2020

How to prevent steroid induced osteoporosis

1 reference

12 December 2020

Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study

1 reference

12 December 2020

Age-dependence of femoral strength in white women and men.

1 reference

12 December 2020

Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors

1 reference

12 December 2020

Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.

1 reference

12 December 2020

Bisphosphonates and other bone agents for breast cancer

1 reference

12 December 2020

Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer

1 reference

12 December 2020

Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial

1 reference

12 December 2020

Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis

1 reference

12 December 2020

Mechanisms of bone lesions in multiple myeloma.

1 reference

12 December 2020

Risk of fracture after androgen deprivation for prostate cancer

1 reference

12 December 2020

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

12 December 2020

Management of treatment-related osteoporosis in men with prostate cancer

1 reference

12 December 2020

Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system

1 reference

12 December 2020

Breast cancer metastasis: markers and models

1 reference

12 December 2020

Bone mineral density changes in patients with prostate cancer during the first 2 years of androgen suppression

1 reference

12 December 2020

Prevalence of osteoporosis among cancer patients in Germany: prospective data from an oncological rehabilitation clinic

1 reference

12 December 2020

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

1 reference

12 December 2020

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

1 reference

12 December 2020

Prevention of osteoporosis after breast cancer

1 reference

12 December 2020

High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy

1 reference

12 December 2020

Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole

1 reference

12 December 2020

Interventions for preventing falls in older people in care facilities and hospitals

1 reference

12 December 2020

Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper.

1 reference

12 December 2020

Metastasis and bone loss: advancing treatment and prevention.

1 reference

12 December 2020

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

1 reference

12 December 2020

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

1 reference

12 December 2020

Global cancer statistics

1 reference

12 December 2020

Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma

1 reference

12 December 2020

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

1 reference

12 December 2020

Bicalutamide 150 mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer

1 reference

12 December 2020

Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion

1 reference

12 December 2020

American College of Sports Medicine roundtable on exercise guidelines for cancer survivors

1 reference

12 December 2020

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

1 reference

12 December 2020

Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor

1 reference

12 December 2020

The vascular system. An overview of structure and function

1 reference

12 December 2020

Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis

1 reference

12 December 2020

Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor

1 reference

12 December 2020

Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites

1 reference

12 December 2020

Some musculo-skeletal sequelae in cancer survivors.

1 reference

12 December 2020

Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.

1 reference

12 December 2020

Guidelines for the diagnosis and management of multiple myeloma 2011

1 reference

12 December 2020

Hormonal deprivation therapy-induced osteoporosis in postmenopausal women with breast cancer

1 reference

12 December 2020

UK guidance document: treatment of metastatic breast cancer

1 reference

12 December 2020

CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease

1 reference

12 December 2020

Bone metastasis: Histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review

1 reference

12 December 2020

The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells

1 reference

12 December 2020

PET and PET/CT imaging of skeletal metastases

1 reference

12 December 2020

Hypogonadism following prostate-bed radiation therapy for prostate carcinoma

1 reference

12 December 2020

Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01)

1 reference

12 December 2020

Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17

1 reference

12 December 2020

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials

1 reference

12 December 2020

Spontaneous radiation-induced rib fractures in breast cancer patients treated with postmastectomy irradiation. A clinical radiobiological analysis of the influence of fraction size and dose-response relationships on late bone damage

1 reference

12 December 2020

10.1007/S00198-013-2530-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24146095 AND SRC:MED&resulttype=core&format=json

28 February 2020

PubMed publication ID

24146095

1 reference